Video

Long-term PERSEUS results confirm sustained benefit of daratumumab-based therapy in newly diagnosed multiple myeloma

Daratumumab and isatuximab show comparable efficacy in newly diagnosed multiple myeloma

ESMO 2026: Bladder and kidney cancer roundup

ESMO 2026: Prostate cancer roundup

Outpatient administration of xaluritamig for mCRPC: Feasibility and safety

Personalised neoantigen vaccine plus radiotherapy improves progression free survival in advanced solid tumours

Tarlatamab improves long term survival in previously treated small cell lung cancer

Mocertatug rezetecan shows promising activity in platinum-resistant ovarian cancer

ABBV-706 shows promising antitumour activity in R/R SCLC

Arcotatug tavatecan improves progression-free survival in CLDN18.2-positive advanced gastric cancer

Zanidatamab plus chemotherapy improves overall survival in HER2-positive advanced gastroesophageal cancer

STRIDE-based immunotherapy plus TACE shows promising outcomes in embolisation-eligible HCC